When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response in the region changes, researchers report. The detailed insights into cancer ...
A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating ...
Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company") is also pleased to announce that its phase 2 clinical study (SKNJCT-003) which is currently ...
Interrupting signals exchanged between tumors and the nervous system could become a critical pillar of cancer care ...
T-VEC enables BCC resectability in 50% of cases, showing promise as a neoadjuvant therapy with mild side effects.
It is a useful therapy with several drawbacks that limit its effectiveness, including prolonged light sensitivity, poor ...
Occupational studies stretching back decades have found an increased risk of bladder cancer among hairdressers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback